Ojemda 25 mg/ml

Ojemda 25 mg/ml is a medicine authorised by Swissmedic under authorisation number 70241. The authorisation holder is IPSEN Pharma Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 05 May 2026 and the authorisation is limited until 05 May 2028. ATC code L01EC04 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 70241
  • ATC L01EC04
  • Synthetic medicines
Authorisation data
Authorisation number70241
NameOjemda 25 mg/ml
Full nameOjemda 25 mg/ml, Pulver zur Herstellung einer Suspension zum Einnehmen
Authorisation holderIPSEN Pharma Schweiz GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01EC04
First authorisation05 May 2026
Authorisation validity05 May 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Ojemda 25 mg/ml, Pulver zur Herstellung einer Suspension zum EinnehmenA05 May 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Flasche(n)L01EC0407.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ojemda 25 mg/ml authorised in Switzerland?

Yes. Ojemda 25 mg/ml is authorised by Swissmedic under authorisation number 70241, data as of 01 September 2026. The authorisation is limited until 05 May 2028.

Which dispensing category does Ojemda 25 mg/ml have?

Ojemda 25 mg/ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ojemda 25 mg/ml?

The authorisation holder is IPSEN Pharma Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com